General Surgery

General Surgery

General Surgery ACS NSQIP Outcomes

January 1, 2023 – December 31, 2023

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall general surgery ACS NSQIP performance benchmarked against 675 participating sites.

General Surgery (675 Sites)NObservedExpected
30 Day Mortalityᵇ12560.96%1.83%
30 Day Morbidity125615.84%16.11%
Cardiacᵇ12560.24%0.97%
Pneumonia12531.20%1.90%
Unplanned Intubation12561.75%1.27%
Ventilator > 48 Hours12521.76%1.36%
Deep Vein Thrombosis (DVT) / Pulmonary Embolusᵃ12564.62%2.21%
Renal Failureᵃ12544.47%2.53%
Urinary Tract Infection (UTI)12551.27%1.55%
Surgical Site Infection (SSI)12518.95%9.38%
Sepsisᵇ12331.70%3.23%
C.diff Colitis12561.04%0.72%
Unplanned Reoperation12564.22%5.17%
Unplanned Readmissionᵃ125614.17%11.51%

American College of Surgeons National Surgical Quality Improvement Program, 2024.
ACS NSQIP® Semiannual Report July 8, 2024ᵇ, Chicago: American College of Surgeons.

ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.

ᵇIdentified as a statistical outlier (lower than expected) by the ACS NSQIP hierarchical model.